Advertisement

Table of Contents

July 01, 1996; Volume 50,Issue 1

You have access
Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer

Molecular Pharmacology July 1996, 50 (1) 1-5;
You have access
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
C Thomsen, V Bruno, F Nicoletti, M Marinozzi and R Pellicciari

Molecular Pharmacology July 1996, 50 (1) 6-9;
You have access
Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.
J L Barwick, L C Quattrochi, A S Mills, C Potenza, R H Tukey and P S Guzelian

Molecular Pharmacology July 1996, 50 (1) 10-16;
You have access
Effect of phorbol myristate acetate on alpha 1-adrenergic action in cells expressing recombinant alpha 1-adrenoceptor subtypes.
J Vázquez-Prado and J A García-Sáinz

Molecular Pharmacology July 1996, 50 (1) 17-22;
You have access
Alpha 6 and gamma 2 subunit antisense oligodeoxynucleotides alter gamma-aminobutyric acid receptor pharmacology in cerebellar granule neurons.
W J Zhu, J F Wang, S Vicini and D R Grayson

Molecular Pharmacology July 1996, 50 (1) 23-33;
You have access
Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
N Almaula, B J Ebersole, J A Ballesteros, H Weinstein and S C Sealfon

Molecular Pharmacology July 1996, 50 (1) 34-42;
You have access
mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
M Yoshimura, H Ikeda and B Tabakoff

Molecular Pharmacology July 1996, 50 (1) 43-51;
You have access
Bimodal distribution of renal cytochrome P450 3A activity in humans.
B D Haehner, J C Gorski, M Vandenbranden, S A Wrighton, S K Janardan, P B Watkins and S D Hall

Molecular Pharmacology July 1996, 50 (1) 52-59;
You have access
Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
S Cavallaro, A Copani, V D'Agata, S Musco, S Petralia, C Ventra, F Stivala, S Travali and P L Canonico

Molecular Pharmacology July 1996, 50 (1) 60-66;
You have access
Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
J M Peters, Y C Zhou, P A Ram, S S Lee, F J Gonzalez and D J Waxman

Molecular Pharmacology July 1996, 50 (1) 67-74;
You have access
Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
F Mesange, F Delarue, J Puel, F Bayard and J C Faye

Molecular Pharmacology July 1996, 50 (1) 75-79;
You have access
k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release.
M L Simmons and C Chavkin

Molecular Pharmacology July 1996, 50 (1) 80-85;
You have access
KINFIT II: a nonlinear least-squares program for analysis of kinetic binding data.
G E Rovati, R Shrager, S Nicosia and P J Munson

Molecular Pharmacology July 1996, 50 (1) 86-95;
You have access
Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
P P Lakhlani, D M Lovinger and L E Limbird

Molecular Pharmacology July 1996, 50 (1) 96-103;
You have access
Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
S Bhattacharya and J Linden

Molecular Pharmacology July 1996, 50 (1) 104-111;
You have access
Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
D R Gehlert, D A Schober, L Beavers, R Gadski, J A Hoffman, D L Smiley, R E Chance, I Lundell and D Larhammar

Molecular Pharmacology July 1996, 50 (1) 112-118;
You have access
Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
E C Burgard, E I Tietz, T R Neelands and R L Macdonald

Molecular Pharmacology July 1996, 50 (1) 119-127;
You have access
B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells.
S A Mathis, N L Criscimagna and L M Leeb-Lundberg

Molecular Pharmacology July 1996, 50 (1) 128-139;
You have access
Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
N H Lee, N S Geoghagen, E Cheng, R T Cline and C M Fraser

Molecular Pharmacology July 1996, 50 (1) 140-148;
You have access
Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
K D Tew, A Monks, L Barone, D Rosser, G Akerman, J A Montali, J B Wheatley and D E Schmidt

Molecular Pharmacology July 1996, 50 (1) 149-159;
You have access
2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
G S Ahluwalia, W Y Gao, H Mitsuya and D G Johns

Molecular Pharmacology July 1996, 50 (1) 160-165;
You have access
Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
P A Witt-Enderby and M L Dubocovich

Molecular Pharmacology July 1996, 50 (1) 166-174;
You have access
Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
H Zhong, S W Guerrero, T A Esbenshade and K P Minneman

Molecular Pharmacology July 1996, 50 (1) 175-184;
You have access
Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits.
Y F Lin, T P Angelotti, E M Dudek, M D Browning and R L Macdonald

Molecular Pharmacology July 1996, 50 (1) 185-195;
You have access
A novel irreversible antagonist of the A1-adenosine receptor.
M Srinivas, J C Shryock, P J Scammells, J Ruble, S P Baker and L Belardinelli

Molecular Pharmacology July 1996, 50 (1) 196-205;
You have access
Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
V K Gribkoff, J T Lum-Ragan, C G Boissard, D J Post-Munson, N A Meanwell, J E Starrett, E S Kozlowski, J L Romine, J T Trojnacki, M C Mckay, J Zhong and S I Dworetzky

Molecular Pharmacology July 1996, 50 (1) 206-217;